Pelabresib,Ruxolitinib
morphosys
['$mor', 'morphosys']
$mor new article : morphosys presents multiple analyses of the manifest phase 2 trial investigating the potential of pelabresib in the treatment of myelofibrosis at eha 2022 get all the latest $mor related news here : 
We'll make staying up-to-date on financials news easy for you. Discover how https://t.co/qYtx6dQ3dV revolutionizes how you gather financial related news